Health, pharma, science writer for Reuters. Any opinions are mine.

Breaking the mould - GSK picks Big Pharma's first female CEO

uk.reuters.com — LONDON Emma Walmsley, GlaxoSmithKline's (GSK.L) incoming CEO, breaks the mould as the first woman to lead a top global drugmaker and stands out among Big Pharma bosses as a consumer brands guru rather than a prescription medicines expert.

Hard to swallow: emerging markets get tougher for drugmakers

in.finance.yahoo.com — By Ben Hirschler LONDON (Reuters) - Emerging markets have lost their lustre for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building.

Hard to swallow: emerging markets get tougher for drugmakers

wkzo.com — By Ben Hirschler LONDON (Reuters) - Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building. A few years ago, the developing world was seen as a savior as patent after patent expired across the United States and Eur...

Hard to swallow: emerging markets get tougher for drugmakers

reuters.com — LONDON Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building.

Hard to swallow: emerging markets get tougher for drugmakers

740thefan.com — By Ben Hirschler LONDON (Reuters) - Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building. A few years ago, the developing world was seen as a savior as patent after patent expired across the United States and Eur...

Hard to swallow: emerging markets get tougher for drugmakers

1660thefan.com — By Ben Hirschler LONDON (Reuters) - Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building. A few years ago, the developing world was seen as a savior as patent after patent expired across the United States and Eur...

Hard to swallow: emerging markets get tougher for drugmakers

wixx.com — By Ben Hirschler LONDON (Reuters) - Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building. A few years ago, the developing world was seen as a savior as patent after patent expired across the United States and Eur...

Hard to swallow: emerging markets get tougher for drugmakers

finance.yahoo.com — Emerging markets have lost their luster for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building.

Hard to swallow: emerging markets get tougher for drugmakers

dailymail.co.uk — LONDON, Sept 22 (Reuters) - Emerging markets have lost their lustre for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building.

Hard to swallow - emerging markets get tougher for drugmakers

uk.news.yahoo.com — By Ben Hirschler LONDON (Reuters) - Emerging markets have lost their lustre for Big Pharma making drug firms ever more dependent on the United States for growth just as American anger over high medicine prices is building.
More Articles →
Sep 24, 2016

RT @Laurie_Garrett: The envelope please: it's official: 6 candidates 4 DirectorGeneral @WHO announced today. UK, France, Hungary, Ethio… https://t.co/1ONwaW1VCG

Sep 24, 2016

RT @WSJhealth: Merck's Keytruda Finds Fast Entry Into China Via Medical-Tourism Push  http://on.wsj.com/2cU6Mba 

Sep 24, 2016

RT @Scientists4EU: Dear @MinistryBrexit, we wish to invoke our EU consumer rights & return your product - it doesn't work as advertised htt…

Sep 24, 2016

#FDA approves Amgen's copy of AbbVie arthritis drug #Humira ... But when will it get to market?  http://reut.rs/2cSSzLD 

Sep 22, 2016

Hard to swallow: emerging markets get tougher for drugmakers  http://reut.rs/2d2JRIH  #pharma

Sep 22, 2016

Something to 'like' at #Facebook -- Chan Zuckerberg Initiative pledges $3 billion to fight #disease  http://reut.rs/2cL7wzh 


Are You a Journalist?

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Create a Portfolio